Grifols SA (GRFS)

7.80 -0.08 (-1.02%) USD  |  NASDAQ  |  Sep 04, 16:00
7.79 -0.01 (-0.13%) After-Hours: 20:00
More

Grifols SG&A Expense (TTM) : 1.318B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 1.318B
March 31, 2026 1.320B
December 31, 2025 1.333B
September 30, 2025 1.300B
June 30, 2025 1.318B
March 31, 2025 1.332B
December 31, 2024 990.74M
September 30, 2024 1.083B
June 30, 2024 1.059B
March 31, 2024 1.036B
December 31, 2023 1.357B
September 30, 2023 1.286B
June 30, 2023 1.271B
March 31, 2023 1.222B
March 31, 2021 1.159B
December 31, 2020 1.125B
September 30, 2020 1.087B
June 30, 2020 1.079B
March 31, 2020 1.065B
December 31, 2019 1.055B
September 30, 2019 1.041B
June 30, 2019 1.001B
March 31, 2019 992.91M
December 31, 2018 960.70M
September 30, 2018 949.44M
Date Value
June 30, 2018 958.93M
March 31, 2018 959.24M
December 31, 2017 970.49M
September 30, 2017 946.44M
June 30, 2017 900.59M
March 31, 2017 887.31M
December 31, 2016 857.22M
September 30, 2016 856.19M
June 30, 2016 860.87M
March 31, 2016 847.07M
December 31, 2015 816.18M
September 30, 2015 797.61M
June 30, 2015 822.55M
March 31, 2015 844.44M
December 31, 2014 878.07M
September 30, 2014 877.35M
June 30, 2014 833.26M
March 31, 2014 783.79M
December 31, 2013 741.96M
September 30, 2013 728.24M
June 30, 2013 709.47M
March 31, 2013 703.80M
December 31, 2012 700.59M
September 30, 2012 581.20M
June 30, 2012 589.53M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
argenx SE 1.537B
Autolus Therapeutics Plc 152.92M
Evaxion AS 4.527M
Pharma Mar SA 73.98M
Oryzon Genomics SA 3.389M